You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國家藥監局就出臺指南徵意見 規範處方藥網絡零售
爲貫徹落實《藥品網絡銷售監督管理辦法》,進一步增強藥品網絡銷售相關方合規意識和能力,規範處方藥網絡零售行爲,國家藥監局組織起草《處方藥網絡零售合規指南(徵求意見稿)》,現向社會公開徵求意見。
徵求意見稿提出,藥品網絡零售企業應當經藥品監督管理部門批準,依法取得藥品經營許可證,嚴格遵守法律、法規、規章、標準和規範。企業在網站首頁或者經營活動的主頁面顯着位置持續公示的相關資質信息,可以通過文本及圖片的形式呈現,確保信息真實、清晰及可讀。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.